PAMFRI to Study Gestational Diabetes Among Asian Americans
Researchers at the Palo Alto Medical Foundation Research Institute (PAMFRI) have received a $300,000 grant from the American Diabetes Association to conduct a three-year study on gestational diabetes among Asian Americans.
Gestational diabetes is high blood sugar (glucose) that starts or is first diagnosed during pregnancy. Women with gestational diabetes may have increased perinatal health risks and are also at increased risk for the later development of type 2 diabetes. Although Asian Americans have the highest rates of gestational diabetes in the United States, there is limited information regarding racial/ethnic differences in gestational diabetes among Asian American subgroups (Asian Indians, Chinese, Filipino, Japanese, Korean and Vietnamese), compared to Non-Hispanic Whites.
According to the U.S. Census Bureau, Asian Americans are the fastest growing racial/ethnic group in the United States, with a population of more than 14 million – and this figure is projected to reach nearly 34 million by 2050. At the Palo Alto Medical Foundation (PAMF), Asian Americans comprise the largest racial/ethnic minority group of all patients.
UCSF, San Francisco General Hospital Team up with PAMF Research Institute
In July 2012, the Palo Alto Medical Foundation Research Institute (PAMFRI) was awarded a two-year, $883,000 training grant by the U.S. Department of Health & Human Services’ Agency for Healthcare Research and Quality (AHRQ).
The effort is called PARTNERS, an acronym for Patient-centered outcomes research: Applied Research TraNsforming Engaged Real-world Systems. It is a collaboration of PAMFRI, an outstanding research unit embedded within a health care delivery system, the University of California, San Francisco (UCSF), and San Francisco General Hospital and Trauma Center (SFGH) and its network of community health clinics.
“To be more than just a collection of peer-reviewed publications, research needs to be assessed and adopted, often with adaptations, in real-world settings,” said Harold S. Luft, Ph.D., director of the Palo Alto Medical Foundation Research Institute. “This requires researcher understanding of the constraints, expectations and time frames of such settings. Such understanding leads to much better research.
“Scholars in the two-year PARTNERS training program will already have both the clinical and research skills to undertake excellent research, but want to learn about doing such research embedded within, or in true partnerships with, delivery systems. They will be engaged in on-going projects with their mentors as well as developing their own projects in multidisciplinary teams in the three sites.”
A significant component of this research is PAMFRI’s collaboration with the University of California, San Francisco (UCSF) and San Francisco General Hospital and Trauma Center.